LeClair Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LeClair Wealth Partners's BMY Position: Q2 2026 in Review
LeClair Wealth Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 9,922 shares worth $572K. The stake represents 0.3% of the portfolio and ranks #62 among its holdings. This is a return to the name: LeClair Wealth Partners previously reported a position in BMY as recently as Q4 2025.
LeClair Wealth Partners first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $591K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- LeClair Wealth Partners held 9,922 shares of Bristol-Myers Squibb worth $572K as of Q2 2026.
- Bristol-Myers Squibb was a new LeClair Wealth Partners position in Q2 2026.
- Bristol-Myers Squibb made up 0.3% of LeClair Wealth Partners's portfolio in Q2 2026, its #62 holding.
- LeClair Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- LeClair Wealth Partners's Bristol-Myers Squibb position peaked at $591K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on LeClair Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.